Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: A prospective study to evaluate the role of non-invasive tests

Arthritis Research and Therapy

Volumn 15, Issue 1, 2013, Pages

  Vacca, Alessandra ^a   Montisci, Roberta ^b   Garau, Pietro ^a   Siotto, Paolo ^c   Piga, Matteo ^a   Cauli, Alberto ^a   Ruscazio, Massimo ^b   Meloni, Luigi ^b   Iliceto, Sabino ^d   Mathieu, Alessandro ^a  

^a University Clinic AOU of Cagliari   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c BROTZU HOSPITAL   (Italy)

^d UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; DOBUTAMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY FLOW RESERVE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EPIDCARDIUM STENOSIS; FOLLOW UP; FUNCTION TEST; HEART LEFT VENTRICLE WALL; HUMAN; MICROANGIOPATHY; MULTIDETECTOR COMPUTED TOMOGRAPHY; MYOCARDIAL DISEASE; OUTCOME ASSESSMENT; PROGNOSIS; PROSPECTIVE STUDY; STRESS ECHOCARDIOGRAPHY; SURVIVAL RATE; SYSTEMIC SCLEROSIS; CORONARY BLOOD VESSEL; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; MALE; MICROCIRCULATION; MIDDLE AGED; PROCEDURES;

ADULT; AGED; CORONARY VESSELS; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC;

EID: 84872042768     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar4136     Document Type: Article

References (48)

1. Black C, Myers A. Current topics in rheumatology: Systemic Sclerosis (Scleroderma). Proceedings of the International Conference on Progressive Systemic Sclerosis 1981, 20-23. Austin, TX, USA, Oct.
2. Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM. Myocardial lesions of progressive systemic sclerosis: a cause of cardiac dysfunction. Circulation 1976, 53:483-490. 10.1161/01.CIR.53.3.483, 1248080.
3. Deswal A, Follansbee WP. Cardiac involvement in scleroderma. Rheum Dis Clin North Am 1996, 22:841-861. 10.1016/S0889-857X(05)70304-5, 8923599.
4. Roberts NK, Cabeen WR, Moss J, Clements PJ, Furst DE. The prevalence of conduction defects and cardiac arrhythmias in progressive systemic sclerosis. Ann Intern Med 1981, 94:38-40.
5. Follansbee WP. The cardiovascular manifestation of systemic sclerosis (scleroderma). Curr Probl Cardiol 1986, 11:241-298.
6. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA, Lucas M, Michet CJ, Kuwana M, Yasuoka H, Van Den Hoogen F, Te Boome L, van Laar JM, Verbeet NL, Matucci-Cerinic M, Georgountzos A, Moutsopoulos HM. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005, 118:2-10. 10.1016/j.amjmed.2004.04.031, 15639201.
7. Ferri C, Giuggioli D, Sebastiani M, Colaci M, Emdin M. Heart involvement and systemic sclerosis. Lupus 2005, 14:702-707. 10.1191/0961203305lu2204oa, 16218471.
8. Kahan A, Allanore Y. Primary myocardial involvement in systemic sclerosis. Rheumatology 2006, 45:iv14-17. 10.1093/rheumatology/kel312, 16980717.
9. Ngian GS, Sahhar J, Wicks IP, Van Doornum S. Cardiovascular disease in systemic sclerosis - an emerging association?. Arthritis Res Ther 2011, 13:237. 10.1186/ar3445, 3239376, 21888685.
10. Follansbee WP, Curtiss EI, Medsger TA, Owens GR, Steen VD, Rodnan GP. Myocardial function and perfusion in the CREST Syndrome variant of progressive systemic sclerosis. Exercise radionuclide evaluation and comparison with diffuse scleroderma. Am J Med 1984, 77:489-496. 10.1016/0002-9343(84)90110-4, 6475990.
11. James TN. De subitaneis mortibus. VIII. Coronary arteries and conduction system in scleroderma heart disease. Circulation 1974, 50:844-856. 10.1161/01.CIR.50.4.844, 4425013.
12. Kahaleh MB. The role of the vascular endothelium in scleroderma pathogenesis. Clin Exp Rheumatol 1998, 16:360.
13. Todesco S, Gatta A, Glorioso S, Chioin R, Peserico A, Zuin R, Merkel C. Cardiac involvement in progressive systemic sclerosis. Acta Cardiol 1979, 5:311.
14. Kahan A, Nitenberg A, Foult JM, Amor B, Menkes CJ, Devaux JY, Blanchet F, Perennec J, Lutfalla G, Roucayrol JC. Decreased coronary reserve in primary scleroderma myocardial disease. Arthritis Rheum 1985, 28:637-646. 10.1002/art.1780280607, 4004974.
15. Montisci R, Vacca A, Garau P, Colonna P, Ruscazio M, Passiu G, Iliceto S, Mathieu A. Detection of early impairment of coronary flow reserve in patients with systemic sclerosis. Ann Rheum Dis 2003, 69:890-893.
16. Sulli A, Ghio M, Bezante GP, Deferrari L, Craviotto C, Sebastiani V, Setti M, Barsotti A, Cutolo M, Indiveri F. Blunted coronary flow reserve in systemic sclerosis. Rheumatology 2004, 43:505-509. 10.1093/rheumatology/keh087, 14734787.
17. Alexander EL, Firestein GS, Weiss JL, Heuser RR, Leitl G, Wagner HN, Brinker JA, Ciuffo AA, Becker LC. Reversible cold-induced abnormalities myocardial perfusion and function in systemic sclerosis. Ann Intern Med 1986, 105:661-668.
18. Gustafsson R, Mannting F, Kazzam E, Waldenstrom A, Hallgren R. Cold induced reversible myocardial ischaemia in systemic sclerosis. Lancet 1989, 2:475-479.
19. Steen VD, Follansbee WP, Conte CG, Medsger TA. Thallium perfusion defects predict subsequent cardiac dysfunction in patients with systemic sclerosis. Arthritis Rheum 1996, 39:677-681. 10.1002/art.1780390421, 8630120.
20. Usher BW, O'Brien TX. Recent advances in dobutamine stress echocardiography. Clin Cardiol 2000, 23:560-570. 10.1002/clc.4960230804, 10941540.
21. Rigo F, Richieri M, Pasanisi E, Cutaia V, Zanella C, Della Valentina P, Di Pede F, Raviele A, Picano E. Usefulness of coronary flow reserve over regional wall motion when added to dual-imaging dipyridamole echocardiography. Am J Cardiol 2003, 91:269-273. 10.1016/S0002-9149(02)03153-3, 12565081.
22. Lim H, Shim WJ, Rhee H, Kim SM, Hwang GS, Kim YH, Seo HS, Oh DJ, Ro YM. Assessment of coronary flow reserve with transthoracic Doppler echocardiography: comparison among adenosine, standard-dose dipyridamole, and high-dose dipyridamole. J Am Soc Echocardiogr 2000, 13:264-270. 10.1067/mje.2000.103508, 10756243.
23. Vacca A, Siotto P, Cauli A, Montisci R, Garau P, Ibba V, Mameli A, Passiu G, Iliceto S, Mathieu A. Absence of epicardial coronary stenosis in systemic sclerosis patients with severe impairment of coronary flow reserve. Ann Rheum Dis 2005, 65:274-275.
24. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and therapeutic Criteria Committee. Arthritis Rheum 1980, 23:581-590. 10.1002/art.1780230510, 7378088.
25. Vacca A, Montisci R, Cauli A, Garau P, Colonna P, Ruscazio M, Passiu G, Meloni L, Iliceto S, Mathieu A. Evaluation of cardiac functional abnormalities in systemic sclerosis by dobutamine stress echocardiography. A myocardial echostress scleroderma pattern (MESP). Ann Rheum Dis 2006, 65:1669-1670. 10.1136/ard.2005.051110, 1798482, 17105858.
26. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989, 2:358-367.
27. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): classification, subset and pathogenesis. J Rheumatol 1988, 15:202-205.
28. Vignaux O, Allanore Y, Meune C, Pascal O, Duboc D, Weber S, Legmann P, Kahan A. Evaluation of the effect of nifedipine upon myocardial perfusion and contractility using cardiac resonance imaging and tissue Doppler echocardiography in systemic sclerosis. Ann Rheum Dis 2005, 64:1268-1273. 10.1136/ard.2004.031484, 1755644, 15708883.
29. Belloli L, Carlo-Stella N, Ciocia G, Chiti A, Massarotti M, Marasini B. Myocardial involvement in systemic sclerosis. Rheumatology 2008, 47:1070-1072. 10.1093/rheumatology/ken186, 18503091.
30. Garau P, Vacca A, Calvisi S, Matta G, De Candia G, Cauli A, Mathieu A. The growing role of cardiac magnetic resonance imaging in assessment and follow-up of pulmonary arterial hypertension associated with systemic sclerosis. Semin Arthritis Rheum 2012, 41:e7-8. 10.1016/j.semarthrit.2011.10.007, 22177106.
31. Hegedus I, Czirjak L. Left ventricular wall motion abnormalities in 80 patients with systemic sclerosis. Clin Rheumatol 1995, 14:161-164. 10.1007/BF02214936, 7789056.
32. Armstrong GP, Whalley GA, Doughty RN. Left ventricular function in scleroderma. Br J Rheumatol 1996, 35:983-988. 10.1093/rheumatology/35.10.983, 8883437.
33. Valentini G, Vitale DF, Giunta A. Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac functional reserve. Ann Rheum Dis 1996, 55:455-460. 10.1136/ard.55.7.455, 1010209, 8774164.
34. Maione S, Cuomo G, Giunta A, Tanturri de Horatio L, La Montagna G, Manguso F, Alagia I, Valentini G. Echocardiographic alterations in systemic sclerosis: a longitudinal study. Semin Arthritis Rheum 2005, 34:721-727. 10.1016/j.semarthrit.2004.11.001, 15846587.
35. Meune C, Allanore Y, Devaux JY, Dessault O, Duboc D, Weber S, Kahan A. High prevalence of right ventricular sistolic dysfunction in early systemic sclerosis. J Rheumatol 2004, 31:1941-1944.
36. Meune C, Avouac J, Wahbi K, Cabanes L, Wipff J, Mouthon L, Guillevin L, Kahan A, Allanore Y. Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care. A controlled study of 100 consecutive patients. Arthritis Rheum 2008, 58:1803-1809. 10.1002/art.23463, 18512815.
37. Bulkely BH, Klacsmann PG, Hutchins GM. Angina pectoris, myocardial infarction and sudden cardiac death with normal coronary arteries: a clinicopathologic study of 9 patients with progressive systemic sclerosis. Am Heart J 1978, 95:563-569. 10.1016/0002-8703(78)90297-1, 636997.
38. D' Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969, 46:428-440. 10.1016/0002-9343(69)90044-8, 5780367.
39. Akram MR, Handler CE, Williams M, Carulli MT, Andron M, Black CM, Denton CP, Coghlan JG. Angiographically proven coronary artery disease in scleroderma. Rheumatology 2006, 45:1395-1398. 10.1093/rheumatology/kel120, 16606654.
40. Montisci R, Chen L, Ruscazio M, Colonna P, Cadeddu C, Caiati C, Montisci M, Meloni L, Sabino I. Non-invasive coronary flow reserve is correlated with microvascular integrity and myocardial viability after primary angioplasty in acute myocardial infarction. Heart 2006, 92:1113-1118. 10.1136/hrt.2005.078246, 1861096, 16449513.
41. Rigo F, Gherardi S, Galderisi M, Pratali L, Cortigiani L, Sicari R, Picano E. The prognostic impact of coronary flow reserve ossesse by Doppler echocardiography in non-ischemic dilated cardiomyopathy. Eur Heart J 2006, 27:1319-1323. 10.1093/eurheartj/ehi795, 16464914.
42. Follansbee WP, Miller TR, Curtiss EI. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol 1990, 17:656-662.
43. Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L, Gallopin M, Salvadori P, Sorace O, Carpeggiani C, Poddighe R, L'Abbate A, Parodi O. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002, 105:186-193. 10.1161/hc0202.102119, 11790699.
44. Cortigiani L, Rigo F, Galderisi M, Gherardi S, Bovenzi F, Scari R. Diagnostic and prognostic value of doppler echocardiographic coronary flow reserve in the left anterior descending artery. Heart 2011, 97:1758-1765. 10.1136/heartjnl-2011-300178, 21835758.
45. Zamorano J, Mateos BR. Prognosis of coronary flow reserve: a new therapeutic target?. Eur Heart J 2006, 27:1266-1267. 10.1093/eurheartj/ehl011, 16682382.
46. Picano E. Informed consent and communication of risk from radiological and nuclear medicine examinations: how to escape from a communication inferno. BMJ 2004, 329:819-851. 521605, 15472255.
47. Picano E. The risk of inappropriateness in cardiac imaging. Int J Environ Res Public Health 2009, 6:1649-1664. 10.3390/ijerph6051649, 2697934, 19543412.
48. Montisci R, Ruscazio M, Lai S, Vacca A, Cauli A, Passiu G, Montisci M, Meloni L, Mathieu A, Iliceto S. Effect of a single IV administration of l-propionylcarnitine on myocardial microcirculation assessed by coronary flow velocity reserve measurement in patients with systemic sclerosis: a pilot study. Clin Ther 2007, 29:163-171. 10.1016/j.clinthera.2007.01.011, 17379056.